Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

ViiV Healthcare enters collaboration with Radboud University Medical Center

March 1, 2019

New phase I trial evaluates MK-8527 in ART-naive patients with HIV-1

Feb. 26, 2019

AGS signs research agreement with NIAID for experimental HIV/AIDS cell and gene therapy

Feb. 18, 2019

Researchers present novel vaginal rings designed for sustained delivery of 5P12-RANTES

Feb. 14, 2019

Urethral macrophages are HIV reservoir

Feb. 12, 2019

Separating latent from dead HIV genomes

Feb. 5, 2019

CONRAD enrolls women in Kenya to study tenofovir/levonorgestrel and tenofovir intravaginal rings

Jan. 31, 2019

NIAID initiates phase I study of the VRC-HIVRGP096-00-VP HIV vaccine

Jan. 28, 2019

Bionor acquires HIV vaccine candidate Vacc-CRX from Immunor

Jan. 15, 2019

IAVI initiates phase I trial of BG505 SOSIP.664 gp140 in HIV-uninfected subjects

Jan. 9, 2019

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...